Aspen Aerogels, Inc. (ASPN)
NYSE: ASPN · Real-Time Price · USD
3.610
-0.030 (-0.82%)
At close: Apr 28, 2026, 4:00 PM EDT
3.610
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
← View all transcripts

Status Update

Jun 30, 2021

Operator

Ladies and gentlemen, thank you for standing by and welcome to the Aspen Aerogels Update Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star one on your telephone. Please be advised that today's conference is being recorded. If you require further assistance, please press star zero. I would now like to hand the conference over to your speaker today, John Fairbanks. Please go ahead.

John Fairbanks
CFO, Aspen Aerogels

Thanks, Danica. Good morning, and thank you for joining us for the Aspen Aerogels Update Call. I'm John Fairbanks, Aspen's Chief Financial Officer. There are a few housekeeping items that I would like to address before turning the call over to Don Young, Aspen's President and Chief Executive Officer. The press release announcing the detail of Aspen's agreement for a private placement of common stock with Koch Strategic Platforms is available on the investor section of Aspen's website, www.aerogels.com. In addition, the investor section of Aspen's website will contain an archived version of this webcast for approximately one year. Please note that our discussion today may include forward-looking statements, including any statement regarding outlook, expectations, beliefs, projections, estimates, targets, prospects, business plans, and any other statement that is not a historical fact. These forward-looking statements are subject to risks and uncertainties.

Aspen Aerogels' actual results may differ materially from those expressed in these forward-looking statements. A list of factors that could affect the company's actual results can be found in Aspen's press release issued today and are discussed in more detail in the reports Aspen files with the SEC, particularly in the company's most recent annual report on Form 10-K. The company's press release issued today and filings with the SEC can also be found in the investor section of Aspen's website. Forward-looking statements made today represent the company's views as of today, June 30th, 2021. Aspen Aerogels disclaims any obligation to update these forward-looking statements to reflect future events or circumstances. I'll now turn the call over to Don.

Donald Young
President and CEO, Aspen Aerogels

Thank you, John.

Good morning. Thank you for joining us for this call to provide additional commentary on our $75 million private placement with Koch Strategic Platforms, or KSP. Today, I will describe the transaction itself, the value of KSP as a long-term investor in Aspen, and the intended use of proceeds. John and I welcome questions following my brief remarks. The private placement was comprised of 3,462,124 common shares at a price of $21.63, which represents a 10% discount to yesterday's market close. The shares are unregistered, but we are committed to register them within 75 days. The transaction is expected to close today. Koch Strategic Platforms, KSP, is part of Koch Industries, one of the largest privately held companies in the world.

KSP is focused on investing in companies with significant growth potential that is reinforced both by accelerating disruptive trends and also where Koch's broad knowledge, capabilities, and resources can add value beyond the investment dollars. We believe we have the opportunity to double revenue every 24 months through this decade. The challenge associated with this level of growth is significant, and the investment and resources from KSP strengthen our ability to implement our growth strategies. We are focused on ensuring that our PyroThin thermal barriers become OEM-agnostic and the industry standard. We are accelerating the development of our carbon aerogel program within Aspen Battery Materials. We are leveraging our existing strength in energy infrastructure, including in emerging energy technologies. We are also focused on building plant two and the supporting supply chain.

With these opportunities in mind, it is terrific to have KSP's world-class global capabilities available to our team. With the close of KSP's investment today, we will have approximately $100 million on our balance sheet at the end of Q2, which aligns our balance sheet with the size of the opportunity before us. It demonstrates to all automotive and battery OEMs that we have the resources to be an outstanding technology partner and supplier for the long- term. The strength of our balance sheet also allows us to remain aggressive in making strategic investments, including for the construction of our Plant two We are completing site selection, are engaged in design and engineering, and are preparing to purchase long lead-time items and initiate construction.

We plan to build plant two in a modular way, and the exact size and cost of phase one of the plant will be determined by the number of additional PyroThin thermal barrier contracts we win this year. In time, we may require additional capital, and if so, we will explore a variety of paths that may include customer or partner financing, debt, or additional equity. Our shareholders' best interests will always be central to our approach in how we finance Aspen's future growth. KSP's investment bolsters our strategy to leverage our aerogel technology platform into multi-billion-dollar opportunities in high-growth, high-value markets and strengthens our position to be a global technology leader in sustainability. I now would like to turn the call back to the operator and to welcome questions. Thank you.

Operator

Again, ladies and gentlemen, at this time, if you would like to ask a question, press star then the number one. Your first question comes from the line of Eric Stine of Craig-Hallum.

Eric Stine
Senior Research Analyst, Craig-Hallum Capital Group

Hi, Don. Hi, John.

Donald Young
President and CEO, Aspen Aerogels

How are you, Eric?

Eric Stine
Senior Research Analyst, Craig-Hallum Capital Group

Good morning. Doing well. Congrats on what you've announced. So curious, I mean, the commentary on doubling revenues every two years for the end of the decade, clearly that's different commentary, more bullish commentary than you have ever provided. Just curious what you're seeing, what gives you the confidence to put that in print, say that on a conference call, just generally from the market and the specific OEMs that you are engaged with.

Donald Young
President and CEO, Aspen Aerogels

Yeah. Thank you, Eric. We've been clear for some time now that we are targeting a doubling of revenue from 2021 to 2023, which gets us out to that $225 million level, approximately 30% gross margins associated with that. We've also said that we have the opportunity to continue to double revenue, including we've been specific 2023 to 2025 as well. We do feel that we have the opportunity to continue that doubling, and it really comes from the breadth of opportunities that we have, certainly within the PyroThin thermal barrier market addressing thermal runaway, but also in some of our activities in energy infrastructure and in our battery materials business as well as we get a little deeper into the decade. And there's no question that the investment from KSP supports and bolsters those opportunities or our ability to fulfill those opportunities.

So we're feeling very strong about our business today and feel like we're in a very, very strong position to live up to those high expectations.

Eric Stine
Senior Research Analyst, Craig-Hallum Capital Group

Yep. And then clearly, well, with what you have secured here, you're moving forward on Plant two I mean, I would assume, though, that beyond 2025 or if you're getting to 2026, and these are the growth opportunities developing as you anticipate, as you said, that would likely mean that there'd be more capacity to come, obviously a high-class problem, but more needs in support of that. But you can get to at least 2025, I would think. Please confirm, but with Plant two.

Donald Young
President and CEO, Aspen Aerogels

What we have said is that our plant one has roughly $250 million of revenue capacity, and that plant two, again, just rough estimates as we build out phase 1 and subsequent phases, would have about twice that much capacity. That's our outlook today for that facility. We would move as we require additional capacity to perhaps an additional plant when the time comes. But we think the $500 million manufacturing plant is a substantial-sized plant. And it's been clear also with some of our large customers with the longer-term contracts that they would like to have a diversity of supply. And given the protected nature, our version of that is to have multiple plants and for them to derive diversity of supply in that manner. And so, yeah, a $500 million plant two is our target.

Eric Stine
Senior Research Analyst, Craig-Hallum Capital Group

Yep. No, that's great. I guess my mistake. I did not know that it was planned to be that big. So that is great news. I guess last one for me as this market develops on the EV side, you've certainly seen OEMs, I mean, pretty much on a, it seems, continual basis upping their targets, upping their aspirations. So just curious, what has that meant for kind of movement in the three buckets that you always talk about in terms of level of engagement?

Donald Young
President and CEO, Aspen Aerogels

Yeah. Thank you, Eric. You are right. We see it every day upping the commitment. The number of models, doing them sooner as well is a real positive for us as the world moves to electrification. I think we're seeing significant activity levels within that business development funnel, really at all three levels. Additional players coming into the, let's call it the initial engagement part of the funnel, but also significant activities in stage two and the final stage as well. We'll continue, of course, to update you and our investors on progress that we're making, and of course, we have our earnings call coming at the end of July, July 29th.

Eric Stine
Senior Research Analyst, Craig-Hallum Capital Group

Okay. Thank you.

Donald Young
President and CEO, Aspen Aerogels

Thank you, Eric. Appreciate it.

Operator

Your next question comes from the line of Alex Potter of Piper Sandler.

Alexander Potter
Managing Director and Senior Research Analyst, Piper Sandler

Hi, guys. Thanks for taking the call. I had a follow-up question on that one. Obviously, I agree. It's basically indisputable at this point that OEMs are focusing more and more on electrification. The question I had specifically for you is, do you have visibility on the downstream products that you are being specced into? Are these high-volume mass market type products? Are they higher-end luxury type products? Just any commentary you can give around how comfortable you feel with revenue visibility would be helpful.

Donald Young
President and CEO, Aspen Aerogels

Yes. Interesting. And I know you're a keen observer of these things, Alex. What we have seen, we're active in all three major regions. Let me start there. And that sort of suggests, I think, that there's a range of vehicle sizes and models across those regions. We have seen an orientation from certain of the automotive OEMs to start at the larger end of their fleets, maybe the more luxury end of their fleets as they convert. And we have seen that. And John and I have said in the past that a ballpark number of content per vehicle is in the range of $275. We've also said that that can range from $100-$300 per vehicle, to your question, depending on the nature of the vehicle, the size of the vehicle, sedan, SUV, truck, etc.

And so our visibility is really around the announced rollout of various models. And it's a range, I would say, from SUVs and trucks to, I would say, smaller SUVs and sedans type vehicles. Those are the ones that we're furthest along on. I know that's kind of a broad answer, but it's really kind of across the board and multi-regional that we're having our success. It's critical for us, and I mentioned it in my comments, to be OEM-agnostic and to become the industry standard for these thermal barriers. And because not every OEM is going to win. And so it is important that we're kind of across-the-board opportunities and that we're associated with the winners. I can tell you that the ones that we're working most closely with are extremely committed to electrification, and the amount of investments that they are making is significant.

Alexander Potter
Managing Director and Senior Research Analyst, Piper Sandler

Okay. Great. That's helpful. And then maybe one last one, thinking longer- term, if you focus on this committed set of global auto OEMs, clearly they're thinking beyond sort of the three- to five-year rollouts for these vehicle platforms that are coming out in 2022, 2023. If you look toward the end of the decade, how far along are you with these folks in your discussion for more advanced battery materials looking beyond just thermal runaway? Thanks.

Donald Young
President and CEO, Aspen Aerogels

Yeah. It's interesting. So many of the meetings that we've had with the automotive OEMs, we have been, let me say that there have been representatives from the automotive OEM that are focused on, let's call it, Gen one and the rollouts that we're seeing of model year 2022, 2023, 2024 kind of timeframe. But we've had cases too where the team has included representatives who are already focused sort of on the Gen two part of their launches and their battery platforms. And so that's reinforcing for us. As you know, we also have our carbon aerogel program, our Aspen Battery Materials, with a first focus on silicon-rich anode materials. And we are making investments in that to be able to keep up with the demand for evaluation samples to provide to significant battery OEMs and automotive OEMs in their development programs.

And we are going to be able to do that as early as this coming month here in July. And we've, of course, announced previously our work with SK in Korea and with Evonik in Germany. Again, we have a small handful of others that we're quite deep in, and I would characterize them as automotive OEMs, battery OEMs, and emergent companies on the battery side as opposed to some of the standard large companies. And so that development, we're very excited about it. And we do, especially when we think about the decade, we know that it will be a value contributor to us, or we're confident it will be a value contributor to us throughout the, especially in the second part of the decade as we work through these development programs.

We've also, I would say, expanded at least the articulation of the opportunity to not only be focused on supplying that silicon-rich anode material, but also to provide our carbon aerogel, our host materials, our scaffolding material for others to imprint, if you will, their own silicon programs onto this very unique structure that we have, this carbon aerogel nanoporous, highly conductive, our ability to manipulate pore size and uniformity of those pores. We've made significant advancements technically as we've continued to expand our team and our capabilities. So again, it's an important area. This investment from KSP allows us to continue to keep our foot on the accelerator for these kinds of opportunities.

Alexander Potter
Managing Director and Senior Research Analyst, Piper Sandler

Great. Thanks a lot for making the time, guys.

Donald Young
President and CEO, Aspen Aerogels

Thanks, Alex.

Operator

Your next question comes from the line of Bill Becker, Northpoint Capital Management.

Donald Young
President and CEO, Aspen Aerogels

Hey, Doug.

Bill Becker
Analyst, Northpoint Capital Management

Thanks. I was hoping to get a little more color on what Koch actually brings to the table as a strategic investor. It looks like yesterday KSP also made an investment in a lithium-ion battery maker. And so maybe if you could just expand on, yes, the capital is very helpful and needed. What else do they bring to the table that maybe we might not appreciate?

Donald Young
President and CEO, Aspen Aerogels

Well, as you know, they are a very, very significant company with significant resources and, let's just say, a business of their own. And those businesses include, for example, Georgia-Pacific, a very, very significant company with significant operations in the state of Georgia and many other places as well. We're focused on building our second plant in that area. And so as we work through the details of site selection and engineering, frankly, the resources that a Koch can bring to us from their experience base are just invaluable to us. To almost feel like it's, well, just to have that strength on our team is terrific. And for us to be able to call on those resources are very important to us. KSP itself has focused on a range of investments, one of which you cited, but they've made several investments in the energy transformation that is going on.

And so, if you think about our own process, let's face it, 90% of our revenues is in energy infrastructure. And we've been very focused on advancing that and being sure that that is an important part of our business. And we've made initial strides in areas. Of course, in LNG, it's been a major contributor to us over the course of the past five years. We believe there are additional energy technologies within energy infrastructure where we can continue to advance. And Koch is very focused on many of those. So again, we feel like we've got an excellent teammate. KSP has made a variety of investments in e-mobility. And I think that creates an ecosystem of itself, again, that can be very beneficial to our company as we move into these new markets.

Bill Becker
Analyst, Northpoint Capital Management

Makes sense. And I know in the past you've mentioned that the balance sheet was definitely of interest to the automotive OEMs. Would you characterize it as a sticking point from preventing the announcement of a second or third thermal barrier contract or just a logical step to moving toward that? And ultimately, just trying to get comfort that another one or two announcements before year-end is still a reasonable expectation.

Donald Young
President and CEO, Aspen Aerogels

It's a good question. There is no. It is clear that, and we know it from our meetings with various automotive OEMs, that they do spend some time on what might be called business continuity, right? They're designing us into significant platforms and programs that they have. And they just want to be sure that we have the ability to keep up with them. And so having a more robust balance sheet, I think, puts some of those kinds of questions to rest. And frankly, to your earlier question, Doug, I think the alignment with KSP also, frankly, supports those kinds of ideas. And so we feel that this was a very, very important investment for us, both from a dollars point of view and also just from the broad shoulders that a KSP brings to the party.

Bill Becker
Analyst, Northpoint Capital Management

And just to try and pin you down. But still reasonable to be expecting an additional announcement or two before year-end, not trying to get too focused on the timing, but.

Donald Young
President and CEO, Aspen Aerogels

That's a fair expectation.

Bill Becker
Analyst, Northpoint Capital Management

Okay. And then just one clarification. Do you think you can get to revenue capacity with plant two of $500 million in 2025 without additional financing? I didn't know if that's what you were trying to imply or just wanted to clarify on that.

Donald Young
President and CEO, Aspen Aerogels

No, I did not. I hope I did not mean to imply that if I did. No. Again, we'll build this in a modular fashion. And so the phase one portion of it will have both our first operating line for additional capacity, but it will also have the infrastructure that will support subsequent lines. And it's a little bit out of the playbook of our building of plant one where we actually built that in really three or four different stages over the course of time. And the modularity aspect of it, it works well in the sense that you do not have to necessarily build a gigantic facility with the hope that somebody comes. We can build it as we win these contracts and as we have continued visibility on winning these kinds of contracts.

So we're able to make those investment decisions with more confidence building it in this manner. But we'll be able to continue to expand it in subsequent phases until we get out to that kind of $500 million revenue target number. That's our current thinking.

Bill Becker
Analyst, Northpoint Capital Management

Right, right. Got it. And just fair to say that with $100 million, give or take, on the balance sheet shortly, don't need to raise additional capital in the short term, but in the intermediate term, probably likely.

Donald Young
President and CEO, Aspen Aerogels

I think that's a good assumption as well, Doug. Yeah.

Bill Becker
Analyst, Northpoint Capital Management

Thank you very much.

Donald Young
President and CEO, Aspen Aerogels

We're in a good spot right now.

Bill Becker
Analyst, Northpoint Capital Management

All right. Thank you.

John Fairbanks
CFO, Aspen Aerogels

Thanks, Doug.

Donald Young
President and CEO, Aspen Aerogels

Thank you, Doug. Appreciate it.

Operator

Your next question comes from the line of Jed Dorsheimer of Canaccord Genuity.

Jed Dorsheimer
Managing Director, William Blair & Company

Hey, guys. Congratulations. This seems like it's perfectly aligned. So nice job.

Donald Young
President and CEO, Aspen Aerogels

Thank you.

John Fairbanks
CFO, Aspen Aerogels

That's good.

Jed Dorsheimer
Managing Director, William Blair & Company

I guess first question regarding, so I guess just with respect to KSP, was their interest spread equally between the energy side and transportation side, or was there a heavier weighting in terms of the opportunity as they looked at and kind of went through their diligence process?

Donald Young
President and CEO, Aspen Aerogels

KSP itself is very focused on new energy technologies and the transformation, and so I would put them a little bit more on the spectrum of our electrification opportunities. Having said that, I think it's also fair to say that KSP can well relate to the transformation that we're making as a company. Again, as I said earlier, 90% plus of our revenue from energy infrastructure. We've laid a strategy that we're executing, I think, quite effectively to have our own sort of transformation, and it's not that we're going to move entirely from one to the other. We're adding. Our energy infrastructure remains interesting and important to our company, and we believe that our value propositions, really, around resource efficiency, asset resiliency, safety will resonate yet even more in the next sort of phase of what's called traditional energy.

And as we've talked about before, Jed, the LNG business has been interesting and successful to us. We also have further opportunities from there. And let's call it, as we've talked about, say, in the hydrogen space and the significant opportunities around thermal management there. And we're deeply rooted in cryogenic thermal management and fire safety around the storage and transportation of these liquid fuels. So there are some terrific emerging companies in that space, but I also believe that that space will have large traditional companies play major roles in the development of the hydrogen economy. And those are many of the companies we've worked with for 15 years. And so.

Jed Dorsheimer
Managing Director, William Blair & Company

Got it. So good strategic fit, kind of interested in the overall business with a heavier weighting on sort of your Pyrogel and the electrification, but not to discount their interest on the other opportunities that you're working on.

Donald Young
President and CEO, Aspen Aerogels

That's fair, Jed.

Jed Dorsheimer
Managing Director, William Blair & Company

So just jumping into the PyroThin and specifically your auto OEM customer a bit more, I guess a specific question. Have you validated your samples with them? Because there is a specific process of going through the qualification. So I guess have you validated your A samples to this OEM or any other OEMs specifically for the Pyrogel?

Donald Young
President and CEO, Aspen Aerogels

Well, so on the thermal barrier side, our PyroThin thermal barriers, as we refer to them as, we have gone through a rigorous program. And not only with our initial North American OEM win, first at a development phase and then in a very rigorous RFQ process, but also our development funnel in this space. That second stage is where they're doing fundamental testing of our materials in the context of thermal runaway. But it's that third stage where we've advanced to fabricating multi-layer parts, doing system testing, system integration in specific models or specific battery platforms, and participating in prototype fleets of vehicles as well. So it is highly tested and integrated into their programs.

Jed Dorsheimer
Managing Director, William Blair & Company

Got it. But autos, even in EVs, has a very specific validation process. So maybe have you already, it sounds like you have, but I guess just to be clear, have you already gone through the sample A validation process at this point, and you're moving towards your C sample process?

Donald Young
President and CEO, Aspen Aerogels

Yeah. I understand what you're referring to from a sequence point of view. The answer is yes. We're responding to specific purchase orders today, Jed, for vehicles to be delivered later in 2021. And so I would just, we're through that process with our most advanced customer and working our way through that process with the next group. And it is moving relatively quickly. And that's why I was confident to answer an earlier question that we will have additional production contracts coming in the months ahead.

Jed Dorsheimer
Managing Director, William Blair & Company

Well, that's great. So I guess last question for me, and then I'll jump back in queue. But if I think of the sequence, and you were kind in terms of pointing out the doubling of revenue every 24 months, which requires and necessitates that new facility. So you have about $100 million of headroom in your current facility that you've gone through the validation and the qualification process with this customer, as you point out, to deliver on product this year. As you think through the adding of the plant, there's going to be an important sequence in terms of in order to hit that doubling because that new plant is going to require a qualification process.

So could you just help me on the timing associated with the qual process of bringing a new plant and from not just building and getting it running, but actually running validation of the qualified product through that plant before you can then recognize those revenues?

Donald Young
President and CEO, Aspen Aerogels

Yeah. That's a good question. So our roadmap to that includes a qualification period, and that comes as we get into the latter part of 2023. And we expect to have that facility, let's say, fully qualified as we move into 2024, Jed. That's the timing that we've laid out, and we're very much on that schedule.

Jed Dorsheimer
Managing Director, William Blair & Company

Listen, congratulations again. Seems like this is a great opportunity. KSP seems well aligned with your strategic vision, and it's really encouraging to see the progress.

Donald Young
President and CEO, Aspen Aerogels

Thank you, Jed. Really appreciate it. We feel very, very fortunate to have this investment in hand.

Operator

Your final question comes from the line of Amit Dayal, H.C. Wainwright.

Amit Dayal
Managing Director and Senior Technology Analyst, H.C. Wainwright & Co.

Good morning, guys. It's Amit from H.C. Wainwright. Thank you for being here.

John Fairbanks
CFO, Aspen Aerogels

Hi, Amit. How are you?

Amit Dayal
Managing Director and Senior Technology Analyst, H.C. Wainwright & Co.

Good. Thank you. Congratulations on securing this investment. Is there any concentration in revenues, guys, in terms of this outlook at this point, at least?

Donald Young
President and CEO, Aspen Aerogels

Well, so the first doubling, which we've been a little more specific about in terms of the path to it. So the first doubling, $225 million, 30% gross margin in 2023. John and I would not have laid that out if we didn't feel we had multiple paths to that number. And those paths include a restoration of our energy infrastructure business back to our 2019 pre-pandemic levels. And we have said along the way that we are confident that there is pent-up demand on that side, both on the maintenance side of the business and on the project side of the business. And we've been encouraged in the early signs here in Q2 of seeing some of that pent-up demand start to play out, especially in regions that are further along in the pandemic than other parts of the world.

So that portion of the 225 feels solid to us. We also have the contract that we have announced previously, which calls for approximately $75 million of revenue in 2023. So those two things alone get us very, very close within five or 10 million dollars of that 225 target. Having said that, we have additional paths, of course, with more automotive OEM wins in the thermal barrier side of the slate. So we have those additional pathways. And perhaps by 2023, the energy infrastructure, just simply saying we're going to get back to 2019 levels, maybe that's a relatively modest goal. And we do believe that we can continue to grow that side of our business over a longer period of time. So again, I would just say that we have multiple paths to that $225 million target number for 2023.

Again, that's accompanied by a 30% growth margin.

Amit Dayal
Managing Director and Senior Technology Analyst, H.C. Wainwright & Co.

Yeah. That was going to be my other question, Don. Just thinking about contribution from any adjacent efforts you're working on, the battery technology itself, would it be too optimistic to assume any contribution from or any material contribution from some of these adjacent efforts as a part of this outlook? Or is most of this outlook based on your view on the opportunity associated with the thermal runaway product?

Donald Young
President and CEO, Aspen Aerogels

Yeah. Certainly, the doubling from 2021 to 2023 is made up of energy infrastructure and thermal barrier work on the automotive OEM side. I think as we look at subsequent doublings, we do have the opportunity to bring in additional revenue sources that I would say include the Aspen Battery Materials work that we're doing. And I think some of the, let's call it, new energy parts of the energy infrastructure side, there are certainly opportunities there that could contribute. Again, those energy infrastructure products can be produced, of course, at our first plant and at our second plant as well. So I haven't mentioned this earlier, but the great part of our plant one and plant two is designed in such a way that we're able to produce both energy infrastructure and PyroThin thermal barriers on the same assets with the same team.

And so we have some flexibility in there as well. And I would add LNG and hydrogen, for example, some of the thermal management challenges on the cryogenic side, again, from that same equipment. So it does provide us flexibility in terms of being prepared to meet a broad range of demand opportunities.

Amit Dayal
Managing Director and Senior Technology Analyst, H.C. Wainwright & Co.

Thank you, guys. That's all I have. Congratulations again.

Donald Young
President and CEO, Aspen Aerogels

Thank you so much.

Operator

At this time, there are no further questions. Thank you.

Donald Young
President and CEO, Aspen Aerogels

Thank you, Tamika. I appreciate it. Thank you for joining us this morning and for your interest, of course, in Aspen Aerogels. This is a terrific day for our company, and we look forward to being with you again to report our second quarter of 2021 results to you on July 29th. Thank you very much. Have a great day.

Operator

This concludes today's conference call. You may now disconnect.

Powered by